Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 887
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +12.2%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 101–106 of 106 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05302284	A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma	recruiting	Phase 3	452	RemeGen Co., Ltd.INDUSTRY	1	Dec 18, 2023	clinicaltrials
NCT06146777	Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy	not yet recruiting	Phase 3	468	First Affiliated Hospital, Sun Yat-Sen UniversityOTHER	0	Nov 29, 2023	clinicaltrials